1-[2-[6-[3-(1,3-benzothiazol-2-ylamino)-4-methyl-6,7-dihydro-5H-pyrido[2,3-c]pyridazin-8-yl]-3-[1-[[3,5-dimethyl-7-(2-pyrrolidin-1-ylethoxy)-1-adamantyl]methyl]-5-methylpyrazol-4-yl]pyridine-2-carbonyl]spiro[3.3]heptan-6-yl]propan-2-one
C54H67N9O3S — CID 176767594
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[2-[6-[3-(1,3-benzothiazol-2-ylamino)-4-methyl-6,7-dihydro-5H-pyrido[2,3-c]pyridazin-8-yl]-3-[1-[[3,5-dimethyl-7-(2-pyrrolidin-1-ylethoxy)-1-adamantyl]methyl]-5-methylpyrazol-4-yl]pyridine-2-carbonyl]spiro[3.3]heptan-6-yl]propan-2-one
1-[2-[6-[3-(1,3-benzothiazol-2-ylamino)-4-methyl-6,7-dihydro-5H-pyrido[2,3-c]pyridazin-8-yl]-3-[1-[[3,5-dimethyl-7-(2-pyrrolidin-1-ylethoxy)-1-adamantyl]methyl]-5-methylpyrazol-4-yl]pyridine-2-carbonyl]spiro[3.3]heptan-6-yl]propan-2-one (PubChem CID 176767594) has the molecular formula C54H67N9O3S and a molecular weight of 922.26 g/mol. Its IUPAC name is 1-[2-[6-[3-(1,3-benzothiazol-2-ylamino)-4-methyl-6,7-dihydro-5H-pyrido[2,3-c]pyridazin-8-yl]-3-[1-[[3,5-dimethyl-7-(2-pyrrolidin-1-ylethoxy)-1-adamantyl]methyl]-5-methylpyrazol-4-yl]pyridine-2-carbonyl]spiro[3.3]heptan-6-yl]propan-2-one.
Molecular Properties
| Compound Name | 1-[2-[6-[3-(1,3-benzothiazol-2-ylamino)-4-methyl-6,7-dihydro-5H-pyrido[2,3-c]pyridazin-8-yl]-3-[1-[[3,5-dimethyl-7-(2-pyrrolidin-1-ylethoxy)-1-adamantyl]methyl]-5-methylpyrazol-4-yl]pyridine-2-carbonyl]spiro[3.3]heptan-6-yl]propan-2-one |
|---|---|
| PubChem CID | 176767594 |
| Molecular Formula | C54H67N9O3S |
| Molecular Weight | 922.26 g/mol |
| Exact Mass | 921.51 |
| IUPAC Name | 1-[2-[6-[3-(1,3-benzothiazol-2-ylamino)-4-methyl-6,7-dihydro-5H-pyrido[2,3-c]pyridazin-8-yl]-3-[1-[[3,5-dimethyl-7-(2-pyrrolidin-1-ylethoxy)-1-adamantyl]methyl]-5-methylpyrazol-4-yl]pyridine-2-carbonyl]spiro[3.3]heptan-6-yl]propan-2-one |
| SMILES | CC(=O)CC1CC2(C1)CC(C(=O)c1nc(N3CCCc4c3nnc(Nc3nc5ccccc5s3)c4C)ccc1-c1cnn(CC34CC5(C)CC(C)(C3)CC(OCCN3CCCC3)(C5)C4)c1C)C2 |
| InChI | InChI=1S/C54H67N9O3S/c1-34(64)21-37-22-52(23-37)24-38(25-52)46(65)45-40(14-15-44(57-45)62-18-10-11-39-35(2)47(59-60-48(39)62)58-49-56-42-12-6-7-13-43(42)67-49)41-26-55-63(36(41)3)33-53-28-50(4)27-51(5,29-53)31-54(30-50,32-53)66-20-19-61-16-8-9-17-61/h6-7,12-15,26,37-38H,8-11,16-25,27-33H2,1-5H3,(H,56,58,59) |
| InChIKey | AIEHDMYMMOEFOZ-UHFFFAOYSA-N |
| XLogP | 10.99 |
| TPSA | 131.26 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 67 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 922.26 |
| LogP ≤ 5 | 10.99 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 13 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176767594 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.